Press release
Rekla.ai Launches AI Breakthrough for SMBs: Automates Ads & Social, Slashes Marketing Costs 90%
New UK-developed AI advertising and social media automation platform enables small businesses to generate instant marketing content, optimize ad spend across 15+ channels like Google & Facebook, and manage social media effortlessly. 14-day free trial available.ILFORD, UK - June 4, 2025 - Rekla Ltd [https://www.rekla.ai] today announced the launch of Rekla.ai, a significant new artificial intelligence (AI) marketing platform designed to empower small and medium-sized businesses (SMBs) by simplifying digital advertising and social media automation. This recently launched system provides SMBs with powerful AI marketing tools to automate tasks, create high-quality AI content generation instantly using simple prompts, and achieve dramatic ad cost reductions of up to 90%, making professional-grade online marketing solutions more accessible than ever for e-commerce brands and local businesses.
Rekla.ai addresses key challenges for SMBs by offering a unified solution for multi-channel AI advertising campaigns. The platform's core AI engine allows users to "just write a prompt" to generate ads and automated social media posts immediately. It intelligently manages advertising across 15+ platforms including Google Ads, Facebook Ads, and TikTok Ads, optimizing budgets and AI audience targeting for maximum marketing ROI and lead generation. Features include AI-driven ad creative generation (text, images via Shutterstock, video), automated A/B testing, and AI audience building. For social media, Rekla.ai automates post creation, meme generation, and scheduling with an intuitive content calendar AI, all from a centralized dashboard.
"With Rekla.ai, we are leveling the playing field for small business marketing, giving them access to sophisticated AI tools that are both powerful and incredibly easy to use," said a spokesperson for Rekla Ltd. "The ability to slash ad spend while simultaneously improving campaign reach and engagement is a game-changer for entrepreneurs looking to grow efficiently with a leading digital advertising platform."
Key Features & Benefits for SMBs:
*
Significant Ad Cost Reduction: AI algorithms optimize spend across channels, potentially cutting marketing costs by up to 90%.
*
Instant AI Content Generation: Generate ads and social posts simply by writing a text prompt.
*
Unified Multi-Channel Management: Control AI advertising and social media automation for 15+ platforms.
*
AI-Powered Ad Creative: Access AI-generated ad copy, images (Shutterstock integrated), and video.
*
Automated Campaign Optimization: Includes A/B testing and AI-driven audience targeting.
*
Effortless Social Media Automation: AI post generation, meme creation, scheduling, and content calendar management.
*
Data-Driven Insights: Analytics to track performance and refine small business marketing solutions.
*
AI Landing Page Builder: (Available in Pro Plan) Quickly create conversion-focused landing pages.
Availability and Pricing:
Rekla.ai is now globally available. A 14-day free trial is offered for all plans. Subscription tiers include:
*
STARTER (44/month): AI Social Media Automation.
*
BOOSTER (79/month): Adds Facebook & Instagram AI Ads.
*
PRO (159/month): Full suite with 15+ platform AI Ads & AI Landing Page Builder. All plans include unlimited AI access with no token charges.
Take Action: SMBs looking to enhance their digital advertising, reduce costs, and save time with social media automation are encouraged to visit https://www.rekla.ai/gb/ to learn more and start their free trial.
About Rekla Ltd:
Rekla Ltd, based in Ilford, UK, develops innovative AI marketing tools to make digital advertising accessible and effective for businesses worldwide.
Media Contact: Media Relations Rekla Ltd press@rekla.ai [mailto:press@rekla.ai]
Media Contact
Company Name: Rekla Ltd
Contact Person: Peter C
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=reklaai-launches-ai-breakthrough-for-smbs-automates-ads-social-slashes-marketing-costs-90]
Country: United Kingdom
Website: https://www.rekla.ai/gb/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rekla.ai Launches AI Breakthrough for SMBs: Automates Ads & Social, Slashes Marketing Costs 90% here
News-ID: 4052323 • Views: …
More Releases from ABNewswire

How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg
Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject.
Essential Platform Features for Effective Online Chemistry Tutoring
Modern chemistry tutoring…

Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious…

Diabetic Retinopathy Pipeline Drugs Report 2025: Emerging Therapies, Clinical De …
DelveInsight's, "Diabetic Retinopathy Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Retinopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by…

Diabetic Macular Edema Pipeline Outlook Report 2025: Emerging Therapies, Clinica …
DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Diabetic Macular Edema pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our…